Jefferies Maintains Intuitive Surgical(ISRG.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Intuitive Surgical (ISRG) and Bio-Rad Laboratories (BIO)
Redburn Atlantic Adjusts Price Target on Intuitive Surgical to $610 From $625, Maintains Buy Rating
Intuitive Surgical Price Target Cut to $635.00/Share From $684.00 by Barclays
Barclays Maintains Overweight on Intuitive Surgical, Lowers Price Target to $635
Intuitive Surgical Analyst Ratings
A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $530 to $675
RBC Capital Maintains Outperform on Intuitive Surgical, Lowers Price Target to $605
Intuitive Surgical Is Maintained at Overweight by Piper Sandler
Barclays Adjusts Price Target on Intuitive Surgical to $635 From $684
Evercore ISI Adjusts Price Target on Intuitive Surgical to $470 From $510, Maintains In Line Rating
Wells Fargo Adjusts Price Target on Intuitive Surgical to $559 From $687, Maintains Overweight Rating
Jefferies Adjusts Price Target on Intuitive Surgical to $530 From $582, Maintains Hold Rating
BTIG Adjusts Price Target on Intuitive Surgical to $542 From $560, Maintains Buy Rating
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $569 From $588, Maintains Buy Rating
Intuitive Surgical Analyst Ratings
Research Alert: Intuitive Surgical Outperforms In Q1 With A 3% Top-line Beat
Baird Maintains Outperform on Intuitive Surgical, Lowers Price Target to $575
Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Intuitive Surgical (ISRG)
Analysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX), Intuitive Surgical (ISRG) and Century Therapeutics (IPSC)